Don't miss our holiday offer - up to 50% OFF!
Tirzepatide: The Dual-Agonist Peptide in Metabolic Research
A dual GIP/GLP-1 agonist central to metabolic research.
Tirzepatide is a dual-agonist peptide that has become a major reference point in metabolic and glucose-regulation research.
What it is
Tirzepatide is studied as an agonist at both the GIP and GLP-1 receptors — two incretin pathways involved in metabolic signaling. This dual mechanism is central to research interest.
Why it’s studied
Research models use tirzepatide to investigate how combined GIP/GLP-1 activation influences glucose handling and energy metabolism relative to single-pathway compounds.
Quality matters
As a compound used quantitatively in research, documented purity and identity are essential — per-batch COAs and third-party HPLC testing.
Research-grade Tirzepatide from Prestige Sciences — ≥99% purity by HPLC, a Certificate of Analysis on every batch, U.S.-shipped with insured delivery.
For laboratory and research use only. Not for human or veterinary consumption. This article is educational and describes published research; it is not medical advice and makes no product claims.